Stimulation through the T cell receptor leads to interactions between SHB and several signaling proteins.

Abstract:

:Shb is a recently described Src homology 2 (SH2) domain-containing adaptor protein. Here we show that Shb is expressed in lymphoid tissues, and is recruited into signaling complexes upon activation of Jurkat T cells. Grb2 binds proline-rich motifs in Shb via its SH3 domains. As a result, a number of proteins detected in anti-Shb and anti-Grb2 immunoprecipitates are shared, including phosphoproteins of 22, 36/38, 55/57 and 70 kDa. Shb-association with p22, which represents the T cell receptor associated zeta chain, occurs through the Shb SH2 domain. The central region of Shb binds p36/38. Since this interaction was inhibited by phosphotyrosine, this region of Shb is likely to contain a non-SH2 PTB (phosphotyrosine binding) domain. The Shb PTB domain was found to preferentially bind the sequence Asp-Asp-X-pTyr when incubated with a phosphopeptide library. A peptide corresponding to a phosphorylation site in 34 kDa Lnk inhibited association between Shb and p36/38. Overexpression of Shb in Jurkat cells led to increased basal phosphorylation of Shb-associated p36/38 and p70 proteins. Inactivation of the Shb SH2 domain by an R522K mutation resulted in a reduced stimulation of tyrosine phosphorylation of several proteins in response to CD3 crosslinking when expressed in Jurkat cells. Together, our results show three distinct domains of Shb all participate in the formulation of multimeric signaling complexes in activated T cells. These results indicate that the Shb protein functions in T cell receptor signaling.

journal_name

Oncogene

journal_title

Oncogene

authors

Welsh M,Songyang Z,Frantz JD,Trüb T,Reedquist KA,Karlsson T,Miyazaki M,Cantley LC,Band H,Shoelson SE

doi

10.1038/sj.onc.1201607

subject

Has Abstract

pub_date

1998-02-19 00:00:00

pages

891-901

issue

7

eissn

0950-9232

issn

1476-5594

journal_volume

16

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element.

    abstract::The short isoform of single-minded 2 (SIM2s), a basic helix-loop-helix/PAS (bHLH/PAS) transcription factor, is upregulated in pancreatic and prostate tumours; however, a mechanistic role for SIM2s in these cancers is unknown. Microarray studies in prostate DU145 cells identified the pro-cell death gene, BNIP3 (Bcl-2/a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.228

    authors: Farrall AL,Whitelaw ML

    更新日期:2009-10-15 00:00:00

  • Overexpression of estrogen receptor-alpha gene suppresses gap junctional intercellular communication in endometrial carcinoma cells.

    abstract::Stimulation of the endometrium by estrogens without the differentiating effect of progestins is the primary etiological factor associated with the development of endometrial hyperplasia and adenocarcinoma. However, the correlation between sex steroids and gap junctional intercellular communication (GJIC), which is con...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207215

    authors: Saito T,Tanaka R,Wataba K,Kudo R,Yamasaki H

    更新日期:2004-02-05 00:00:00

  • PMP24, a gene identified by MSRF, undergoes DNA hypermethylation-associated gene silencing during cancer progression in an LNCaP model.

    abstract::Transcriptional silencing of antitumor genes via CpG island methylation could be a mechanism mediating prostate cancer (PCa) progression from an androgen-sensitive (AS) to an androgen-insensitive (AI) state. We have used the methylation-sensitive restriction fingerprinting (MSRF) technique to identify novel CpG-rich s...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207076

    authors: Wu M,Ho SM

    更新日期:2004-01-08 00:00:00

  • Delaying mitotic exit downregulates FLIP expression and strongly sensitizes tumor cells to TRAIL.

    abstract::Many of the current antitumor therapeutic strategies are based on the perturbation of the cell cycle, especially during mitosis. Antimitotic drugs trigger mitotic checkpoint activation, mitotic arrest and eventually cell death. However, mitotic slippage represents a major mechanism of resistance to these treatments. I...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.601

    authors: Sánchez-Pérez T,Medema RH,López-Rivas A

    更新日期:2015-01-29 00:00:00

  • Oxamflatin: a novel compound which reverses malignant phenotype to normal one via induction of JunD.

    abstract::In the course of screening for inhibitors of tumorigenic phenotype of K-ras-transformed NIH3T3 cells (DT cells), we found a novel compound, oxamflatin, an aromatic sulfonamide hydroxamate derivative, which induces flat phenotype in these cells and suppresses their anchorage-independent growth. In contrast to DT cells,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sonoda H,Nishida K,Yoshioka T,Ohtani M,Sugita K

    更新日期:1996-07-04 00:00:00

  • Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).

    abstract::An elevated proteasome activity contributes to tumorigenesis, particularly by providing cancer cells with antiapoptotic protection and efficient clearance from irregular proteins. Still, the underlying mechanisms are poorly known. In this study, we report that in colon cancer patients, higher proteasome activity was d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.264

    authors: Arlt A,Bauer I,Schafmayer C,Tepel J,Müerköster SS,Brosch M,Röder C,Kalthoff H,Hampe J,Moyer MP,Fölsch UR,Schäfer H

    更新日期:2009-11-12 00:00:00

  • Stem cell programs are retained in human leukemic lymphoblasts.

    abstract::Leukemic lymphoblasts within different immunophenotypic populations possess stem cell properties. However, whether or not the self-renewal program is retained from stem cells or conferred on progenitors by leukemogenic molecules remains unknown. We have addressed the issue in the context of TEL-AML1-associated acute l...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.148

    authors: Fan D,Zhou X,Li Z,Li ZQ,Duan C,Liu T,Zhang F,Huang Y,Zhang Y,Gao F,Guo Y,Gupta R,Chen G,Enver T,Tang J,Hong D

    更新日期:2015-04-16 00:00:00

  • TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.

    abstract::Transforming growth factor-beta (TGF-β) is a pleiotropic cytokine with the capability to act as tumour suppressor or tumour promoter depending on the cellular context. TGF-beta receptor type-2 (TGFBR2) is the ligand-binding receptor for all members of the TGF-β family. Data from mouse model experiments demonstrated th...

    journal_title:Oncogene

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/onc.2013.527

    authors: Busch S,Acar A,Magnusson Y,Gregersson P,Rydén L,Landberg G

    更新日期:2015-01-02 00:00:00

  • IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth.

    abstract::Chronic obstructive pulmonary disease (COPD) is associated with an increased risk for lung cancer and an aberrant microbiota of the lung. Microbial colonization contributes to chronic neutrophilic inflammation in COPD. Nontypeable Haemophilus influenzae (NTHi) is frequently found in lungs of stable COPD patients and i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.28

    authors: Jungnickel C,Schmidt LH,Bittigkoffer L,Wolf L,Wolf A,Ritzmann F,Kamyschnikow A,Herr C,Menger MD,Spieker T,Wiewrodt R,Bals R,Beisswenger C

    更新日期:2017-07-20 00:00:00

  • Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment.

    abstract::A lot of effort has been done to study how cancer cells react to low-oxygen tension, a condition known as hypoxia. Indeed, abnormal and dysfunctional blood vessels in the tumor are incapable to restore oxygenation, therefore perpetuating hypoxia, which, in turn, will fuel tumor progression, metastasis and resistance t...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.121

    authors: Casazza A,Di Conza G,Wenes M,Finisguerra V,Deschoemaeker S,Mazzone M

    更新日期:2014-04-03 00:00:00

  • Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling.

    abstract::Tumor metastasis, but not primary overgrowth, is the leading cause of mortality for cancer patients. During the past decade, Drosophila melanogaster has been well-accepted as an excellent model to address the intrinsic mechanism of different aspects of cancer progression, ranging from tumor initiation to metastasis. I...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.463

    authors: Ma X,Huang J,Tian Y,Chen Y,Yang Y,Zhang X,Zhang F,Xue L

    更新日期:2017-06-01 00:00:00

  • Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.

    abstract::RAS is a small GTP binding protein mutated in approximately 30% human cancer. Despite its important role in the initiation and progression of human cancer, the underlying mechanism of RAS-induced human epithelial transformation remains elusive. In this study, we probe the cellular and molecular mechanisms of RAS-media...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208753

    authors: Young T,Mei F,Liu J,Bast RC Jr,Kurosky A,Cheng X

    更新日期:2005-09-08 00:00:00

  • hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.

    abstract::In the presence of ERbeta, trans-hydroxytamoxifen (TOT) protects cells against 17beta-estradiol (E(2))-induced oxidative DNA damage (ODD) and this correlates with increased expression of the antioxidative enzyme quinone reductase (QR). Here, we investigate the molecular mechanism responsible for ERbeta-mediated protec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.235

    authors: Sripathy SP,Chaplin LJ,Gaikwad NW,Rogan EG,Montano MM

    更新日期:2008-10-23 00:00:00

  • An RNF11: Smurf2 complex mediates ubiquitination of the AMSH protein.

    abstract::RING-finger proteins play crucial roles in ubiquitination events involved in diverse cellular processes including signal transduction, differentiation and apoptosis. Most of the RING-finger proteins have E3-ubiquitin ligase activity. RNF11 is a small RING-finger protein and harbors a RING-H2 domain and a PY motif that...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207319

    authors: Li H,Seth A

    更新日期:2004-03-11 00:00:00

  • Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.

    abstract::High Mobility Group AT-hook 2 (HMGA2) is a chromatin modifier and its overexpression has been found in patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Level of Hmga2 expression is fine-tuned by Lin28b-Let-7 axis and Polycomb Repressive Complex 2, in which deletion of Ezh2 leads to activa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01629-w

    authors: Bai J,Yokomizo-Nakano T,Kubota S,Sun Y,Kanai A,Iimori M,Harada H,Iwama A,Sashida G

    更新日期:2021-01-15 00:00:00

  • Dissection of the cytoplasmic domains of cytokine receptors involved in STAT and Ras dependent proliferation.

    abstract::Cytokine receptors have different signaling requirements which ultimately lead to various physiological responses. In an effort to precisely characterize the molecular determinants involved in the proliferative response mediated by cytokines, we examine dose-dependent proliferation of the betac (GM-CSF, IL-3, IL-5) an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205444

    authors: Piu F,Magnani M,Ader ME

    更新日期:2002-05-16 00:00:00

  • Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.

    abstract::Formation of meningiomas has been associated with the loss of genetic material on chromosome 22. To approach the additional chromosomal events that underlie progression of these tumors to malignancy, we have examined several other chromosomal regions for loss of heterozygosity (LOH) in these tumors. Fifty-eight tumors...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200853

    authors: Menon AG,Rutter JL,von Sattel JP,Synder H,Murdoch C,Blumenfeld A,Martuza RL,von Deimling A,Gusella JF,Houseal TW

    更新日期:1997-02-06 00:00:00

  • Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.

    abstract::Emerging evidence has shown that cancer stem cells (CSCs) are the cellular determinants to promote cancer invasion and metastasis. However, the mechanism underlying CSC invasion remains unknown. MicroRNAs are evolutionally conserved small noncoding RNAs that are critical for the regulation of gene expression, and thei...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.75

    authors: Wang Z,Wang B,Shi Y,Xu C,Xiao HL,Ma LN,Xu SL,Yang L,Wang QL,Dang WQ,Cui W,Yu SC,Ping YF,Cui YH,Kung HF,Qian C,Zhang X,Bian XW

    更新日期:2015-03-12 00:00:00

  • Platelet-activating factor activates mitogen-activated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells.

    abstract::Recent studies suggest that the action of platelet-activating factor (PAF), a potent phospholipid modulator of allergic and inflammatory reactions, is diverse and functions as a modulator of a variety of physiological and pathological events in many cell types and tissues. Its role (if any) in modulating the prolifera...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206348

    authors: Wang H,Chakrabarty S

    更新日期:2003-04-10 00:00:00

  • The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.

    abstract::The ataxia-telangiectasia-mutated (ATM) kinase is a key transducer of DNA damage signals within the genome maintenance machinery and a tumour suppressor whose germline mutations predispose to familial breast cancer. ATM signalling is constitutively activated in early stages of diverse types of human malignancies and c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210885

    authors: Tommiska J,Bartkova J,Heinonen M,Hautala L,Kilpivaara O,Eerola H,Aittomäki K,Hofstetter B,Lukas J,von Smitten K,Blomqvist C,Ristimäki A,Heikkilä P,Bartek J,Nevanlinna H

    更新日期:2008-04-10 00:00:00

  • Caspase-dependent processing activates the proapoptotic activity of deleted in breast cancer-1 during tumor necrosis factor-alpha-mediated death signaling.

    abstract::Deleted in breast cancer-1 (DBC-1) was initially cloned from a homozygously deleted region in breast and other cancers on human chromosome 8p21, although no function is known for the protein product it encodes. We identified the generation of amino-terminally truncated versions of DBC-1 during tumor necrosis factor (T...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208681

    authors: Sundararajan R,Chen G,Mukherjee C,White E

    更新日期:2005-07-21 00:00:00

  • Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.

    abstract::Acute myeloid leukemia (AML) is a heterogeneous disease comprising a large number of subtypes defined by specific chromosome abnormalities. One such subtype carries the t(6;9)(p22;q34) chromosome rearrangement, which leads to expression of the DEK-NUP214 chimeric gene, and has a particularly poor outcome. To provide a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.118

    authors: Qin H,Malek S,Cowell JK,Ren M

    更新日期:2016-10-27 00:00:00

  • Targeting CK2-driven non-oncogene addiction in B-cell tumors.

    abstract::Genetic mutations of oncogenes often underlie deranged cell growth and altered differentiation pathways leading to malignant transformation of B-lymphocytes. However, addiction to oncogenes is not the only drive to lymphoid tumor pathogenesis. Dependence on non-oncogenes, which act by propelling basic mechanisms of ce...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.86

    authors: Mandato E,Manni S,Zaffino F,Semenzato G,Piazza F

    更新日期:2016-11-24 00:00:00

  • CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzyme UBC3B induces its interaction with beta-TrCP and enhances beta-catenin degradation.

    abstract::Protein kinase CK2 is a ubiquitous and pleiotropic Ser/Thr protein kinase involved in cell growth and transformation. Here we report the identification by yeast interaction trap of a CK2 interacting protein, UBC3B, which is highly homologous to the E2 ubiquitin conjugating enzyme UBC3/CDC34. UBC3B complements the yeas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205574

    authors: Semplici F,Meggio F,Pinna LA,Oliviero S

    更新日期:2002-06-06 00:00:00

  • Decoding whole-genome mutational signatures in 37 human pan-cancers by denoising sparse autoencoder neural network.

    abstract::Millions of somatic mutations have recently been discovered in cancer genomes. These mutations in cancer genomes occur due to internal and external mutagenesis forces. Decoding the mutational processes by examining their unique patterns has successfully revealed many known and novel signatures from whole exome data, b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1343-z

    authors: Pei G,Hu R,Dai Y,Zhao Z,Jia P

    更新日期:2020-07-01 00:00:00

  • EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes.

    abstract::EBP1 was identified as a protein that interacts with the ErbB-3 receptor and possibly contributes to transducing growth regulatory signals. The existence of EBP1 homologs across species from simple eukaryotes to humans and its wide tissue expression pattern suggest that EBP1 acts as a general signaling molecule. We pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207579

    authors: Squatrito M,Mancino M,Donzelli M,Areces LB,Draetta GF

    更新日期:2004-05-27 00:00:00

  • Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice.

    abstract::Functional alterations or loss of tumor-suppressor genes are an important feature of neoplastic progression in humans. The employment of suitable animal model systems would greatly facilitate the detection and manipulation of such genes. We describe here an experimental approach to this problem based on the analysis o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Burns PA,Kemp CJ,Gannon JV,Lane DP,Bremner R,Balmain A

    更新日期:1991-12-01 00:00:00

  • The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance.

    abstract::Birt-Hogg-Dubé syndrome (BHD) is a rare, inherited genodermatosis characterized by hair follicle hamartomas, kidney tumors and spontaneous pneumothorax. The BHD locus was mapped to chromosome 17p11.2 by linkage analysis, and germline mutations in a novel gene (BHD) were identified in a panel of BHD families. Using RNA...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209593

    authors: Singh SR,Zhen W,Zheng Z,Wang H,Oh SW,Liu W,Zbar B,Schmidt LS,Hou SX

    更新日期:2006-09-28 00:00:00

  • Mechanisms of transcription factor deregulation in lymphoid cell transformation.

    abstract::The most frequent targets of genetic alterations in human lymphoid leukemias are transcription factor genes with essential functions in blood cell development. TAL1, LYL1, HOX11 and other transcription factors essential for normal hematopoiesis are often misexpressed in the thymus in T-cell acute lymphoblastic leukemi...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210766

    authors: O'Neil J,Look AT

    更新日期:2007-10-15 00:00:00

  • Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.

    abstract::Mel-18 has been implicated in several processes in tumor progression, in which the Akt pathway is involved as an important key molecular event. However, the function of Mel-18 in human cancers has not been fully established yet. Here, we examined the effect of Mel-18 on tumor angiogenesis in human breast cancer, and f...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.174

    authors: Park JH,Lee JY,Shin DH,Jang KS,Kim HJ,Kong G

    更新日期:2011-11-10 00:00:00